{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:00:23Z","timestamp":1773511223495,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society of Allergology","issue":"4","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":3405,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2006]]},"DOI":"10.2332\/allergolint.55.395","type":"journal-article","created":{"date-parts":[[2006,12,18]],"date-time":"2006-12-18T05:46:08Z","timestamp":1166420768000},"page":"395-402","source":"Crossref","is-referenced-by-count":12,"title":["A Prospective Survey on Safety of Sustained-Release Theophylline in Treatment of Asthma and COPD"],"prefix":"10.2332","volume":"55","author":[{"given":"Sohei","family":"Makino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigenori","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankei","family":"Nishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumasa","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.55.395_bb0005","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1164\/ajrccm.151.6.7767539","article-title":"Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy","volume":"151","author":"Kidney","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.2332\/allergolint.55.395_bb0010","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(94)90127-9","article-title":"Anti-inflammatory effects of low-dose oral theophylline in atopic asthma","volume":"343","author":"Sullivan","year":"1994","journal-title":"Lancet"},{"key":"10.2332\/allergolint.55.395_bb0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1183\/09031936.96.09030456","article-title":"Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics","volume":"9","author":"Jaffar","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.2332\/allergolint.55.395_bb0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/ajrccm.164.2.2006043","article-title":"Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma","volume":"164","author":"Lim","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.2332\/allergolint.55.395_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2222.1996.tb01137.x","article-title":"The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis","volume":"26","author":"Ohta","year":"1996","journal-title":"Clin. Exp. Allergy"},{"key":"10.2332\/allergolint.55.395_bb0030","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI119692","article-title":"Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition","volume":"100","author":"Yasui","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.2332\/allergolint.55.395_bb0035","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1073\/pnas.132556899","article-title":"A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression","volume":"99","author":"Ito","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.2332\/allergolint.55.395_bb0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJM197309202891202","article-title":"Rational intravenous doses of theophylline","volume":"289","author":"Mitenko","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.2332\/allergolint.55.395_bb0045","first-page":"1","article-title":"Asthma prevention and management guidelines 1998, Japan (JGL 1998)","volume":"121","author":"Makino","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.2332\/allergolint.55.395_bb0050","series-title":"Global Strategy for Asthma Management and Prevention NHLBI\/WHO Workshop Report, Global Initiative for Asthma (GINA 1995)","article-title":"National Heart, Lung, and Blood Institute, National Institutes of Health","year":"1995"},{"key":"10.2332\/allergolint.55.395_bb0055","series-title":"The Japanese Respiratory Society Guidelines for the Diagnosis and Management of COPD","year":"2005"},{"key":"10.2332\/allergolint.55.395_bb0060","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease NHLBI\/ WHO Workshop Report. Global Initiative for Chronic Obstructive Lung Disease","article-title":"National Heart, Lung, and Blood Institute, National Institutes of Health","year":"2005"},{"key":"10.2332\/allergolint.55.395_bb0065","unstructured":"ICH Harmonised Tripartite Guideline (EMEA Status as of November 1994). Clinical safety data management: Definitions and standards for expedited reporting."},{"key":"10.2332\/allergolint.55.395_bb0070","first-page":"4915","article-title":"Clinical evaluation of sustained release theophylline (MCI-8019) on chronic obstructive pulmonary disease","volume":"14","author":"Takishima","year":"1986","journal-title":"Yakuri to Chiryo"},{"key":"10.2332\/allergolint.55.395_bb0075","first-page":"861","volume":"4","author":"Miyamoto","year":"1985","journal-title":"Kokyu"},{"key":"10.2332\/allergolint.55.395_bb0080","first-page":"95","article-title":"Study to evaluate the guidelines for determination of the optimal dosage for NI-102S, a sustained-release theophylline preparation, in adult bronchial asthma","volume":"8","author":"Harasawa","year":"1992","journal-title":"Rinsho Iyaku"},{"key":"10.2332\/allergolint.55.395_bb0085","series-title":"Bronchial asthma: mechanisms and therapeutics","first-page":"764","article-title":"Methyxanthines","author":"Weinberger","year":"1993"},{"key":"10.2332\/allergolint.55.395_bb0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-3476(86)80403-6","article-title":"Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma","volume":"109","author":"Milavetz","year":"1986","journal-title":"J. Pediatr."},{"key":"10.2332\/allergolint.55.395_bb0095","first-page":"57","article-title":"Effect of theophylline withdrawal on airway inflammation in asthma","volume":"28","author":"Minoguchi","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"10.2332\/allergolint.55.395_bb0100","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1164\/ajrccm.151.6.7767539","article-title":"Immunomodulation by theophylline in asthma: Demonstration by withdrawal of therapy","volume":"151","author":"Kidney","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.2332\/allergolint.55.395_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0091-6749(98)70187-3","article-title":"Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-moderate asthma","volume":"101","author":"Reed","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2332\/allergolint.55.395_bb0110","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199711133372002","article-title":"A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma","volume":"337","author":"Evans","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.2332\/allergolint.55.395_bb0115","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1183\/09031936.97.10122754","article-title":"Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma","volume":"10","author":"Ukena","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.2332\/allergolint.55.395_bb0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/thorax.55.10.837","article-title":"Comparison of high dose inhaled steroids, low dose inhaled steroid plus low dose theophylline, and low-dose inhaled steroids alone in chronic asthma","volume":"55","author":"Lim","year":"2000","journal-title":"Thorax"},{"key":"10.2332\/allergolint.55.395_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/ajrccm.151.2.7842186","article-title":"Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids","volume":"151","author":"Rivington","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.2332\/allergolint.55.395_bb0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/arrd.1983.127.5.581","article-title":"The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis","volume":"127","author":"Reisz","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.2332\/allergolint.55.395_bb0135","series-title":"Global Strategy for Asthma Management and Prevention NHLBI\/ WHO Workshop Report Revised Global Initiative for Asthma (GINA 2002)","article-title":"National Heart, Lung, and Blood Institute, National Institutes of Health","year":"2002"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015309953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015309953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T05:03:15Z","timestamp":1555995795000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015309953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"alternative-id":["S1323893015309953"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.55.395","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}